Gabelli Funds LLC Bridge Bio Pharma, Inc. Transaction History

Gabelli Funds LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$11.38 - $53.41 $68,280 - $320,460	-6,000 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$46.87 - $64.24 $117,175 - $160,600	-2,500 Reduced 29.41%	6,000 $281,000
Q2 2021 Aug 13, 2021	SELL	$46.47 - $63.93 $195,174 - $268,506	-4,200 Reduced 33.07%	8,500 $518,000
Q1 2021 May 14, 2021	BUY	$55.47 - $72.35 $704,469 - $918,844	12,700 New	12,700 $782,000

291

171M

10.4M

2.37M

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $3.45B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

Get notified when there are updates to the investment portfolio of Gabelli Funds LLC, based on Form 13F filings with the SEC.

Stay updated on Gabelli Funds LLC with notifications on news.